These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11367192)

  • 1. Glaxo Wellcome announces abacavir pricing.
    Newsline People AIDS Coalit N Y; 1999 Jan; ():35. PubMed ID: 11367192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New drug pricing: progress on World AIDS Day?
    James JS
    AIDS Treat News; 1998 Dec; (No 308):8. PubMed ID: 11366077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abacavir's trials and tribulations.
    Gilden D
    GMHC Treat Issues; 1998 Nov; 12(11):1-3. PubMed ID: 11365905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soaring prices, soaring sales.
    Grinberg L
    GMHC Treat Issues; 1998 Dec; 12(12):5-7. PubMed ID: 11366020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abacavir sulfate (Ziagen).
    Simmons P
    Res Initiat Treat Action; 1999 Apr; 5(2):8-10. PubMed ID: 11366289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drug pricing consensus letter, sign-ons requested.
    AIDS Treat News; 1998 Sep; (302):4. PubMed ID: 11365762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziagen (abacavir) approved: caution essential.
    James JS
    AIDS Treat News; 1999 Jan; (No 310):1, 3-6. PubMed ID: 11366148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abacavir at last.
    Gilden D
    GMHC Treat Issues; 1998 Mar; 12(3):9. PubMed ID: 11365394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1592 (abacavir, or new name Ziagen) more widely available March 23.
    AIDS Treat News; 1998 Mar; (No 291):6-7. PubMed ID: 11365246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glaxo Wellcome's two new drugs.
    Res Initiat Treat Action; 1998 Dec; 4(7):14. PubMed ID: 11366081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug prices.
    AIDS Policy Law; 1996 Dec; 11(22):12. PubMed ID: 11364060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity reactions due to abacavir.
    Newsline People AIDS Coalit N Y; 1998 Feb; ():35-6. PubMed ID: 11367446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abacavir warning: certain respiratory symptoms can indicate hypersensitivity reaction.
    AIDS Treat News; 2000 Feb; (No 337):7-8. PubMed ID: 11367210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abacavir expanded access widened.
    Highleyman L
    BETA; 1998 Jan; ():4. PubMed ID: 11364976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advocates call for fair drug pricing.
    Highleyman L
    BETA; 1998 Oct; ():3. PubMed ID: 11365988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abacavir update.
    Proj Inf Perspect; 1998 Dec; (26):11. PubMed ID: 11366488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abacavir for salvage or intensification.
    Torres G
    GMHC Treat Issues; 1999 Jan; 13(1):4-5. PubMed ID: 11366111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded access to experimental drugs: activists seek more open programs.
    Grinberg L
    AIDS Treat News; 1997 Nov; (No 282):6-7. PubMed ID: 11364904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziagen (abacavir): new warning on restarting.
    AIDS Treat News; 2000 Aug; (348):7-8. PubMed ID: 12170990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1592 access: larger program planned.
    Grinberg L; James JS
    AIDS Treat News; 1997 Nov; (No 283):2-3. PubMed ID: 11364908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.